Figures computed from official regulatory filings — .
Analysttarget 3.95 USD (+18%) · consensus 3.36/5 · 4 buy · 8 hold · 2 sell
Ownershipinsiders 12.71% · institutions 55.85% · short 4.9% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for GoodRx Holdings, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
44 buys229 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Fengler Justin | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Chan Thomas (TC) | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Fengler Justin | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Chan Thomas (TC) | Other | $3.8K | SEC |
| Fengler Justin | Other | $1.2K | SEC |
| Fengler Justin | Other | $3.6K | SEC |
| Fengler Justin | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Fengler Justin | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Chan Thomas (TC) | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| FRANCISCO PARTNERS IV, L.P. | Sell | $739K | SEC |
| FRANCISCO PARTNERS IV, L.P. | Sell | $749.6K | SEC |
| FRANCISCO PARTNERS IV, L.P. | Sell | $1.5M | Unusual size | SEC |
| FRANCISCO PARTNERS IV, L.P. | Sell | $1.5M | Unusual size | SEC |
| FRANCISCO PARTNERS IV, L.P. | Sell | $217.7K | SEC |
| FRANCISCO PARTNERS IV, L.P. | Sell | $220.8K | SEC |
| FRANCISCO PARTNERS IV, L.P. | Sell | $250.3K | Unusual size | SEC |
| FRANCISCO PARTNERS IV, L.P. | Sell | $246.8K | Unusual size | SEC |
| FRANCISCO PARTNERS IV, L.P. | Sell | $483.7K | Unusual size | SEC |
| FRANCISCO PARTNERS IV, L.P. | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| FRANCISCO PARTNERS IV, L.P. | Sell | $476.9K | Unusual size | SEC |
| FRANCISCO PARTNERS IV, L.P. | Sell | $839K | SEC |
| FRANCISCO PARTNERS IV, L.P. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| FRANCISCO PARTNERS IV, L.P. | Other | n/a (No price was disclosed in the filing) | SEC |
| FRANCISCO PARTNERS IV, L.P. | Other | n/a (No price was disclosed in the filing) | SEC |
| FRANCISCO PARTNERS IV, L.P. | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |